Labeled iodinated tropane formulation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 12, 2017
Issued Date -
N/A
app pub date -
Oct 17, 2014
filing date -
Oct 31, 2007
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinson's disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [123I]-2β-carbomethoxy-3β-(4-flurophenyl)-N-(3-iodo-E-allyl) nortropane.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
LIKEMINDS INC | 361 NEWBURY STREET 5TH FLOOR BOSTON MA 02115 |
International Classification(s)

- 2014 Application Filing Year
- A61K Class
- 14144 Applications Filed
- 11600 Patents Issued To-Date
- 82.02 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Ferreira, Cara | Vancouver, CA | 4 | 2 |
# of filed Patents : 4 Total Citations : 2 | |||
Leyh, David | Vancouver, CA | 3 | 2 |
# of filed Patents : 3 Total Citations : 2 | |||
Sterzinger, Chris | Vancouver, CA | 3 | 2 |
# of filed Patents : 3 Total Citations : 2 | |||
Thorn, Richard | Boston, US | 12 | 61 |
# of filed Patents : 12 Total Citations : 61 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 8 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Mar 12, 2025 |
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 12, 2029 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Feb 16, 2021 | MAFP | MAINTENANCE FEE PAYMENT | free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 4 |
Feb 11, 2021 | FEPP | FEE PAYMENT PROCEDURE | free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
Jan 04, 2021 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STERZINGER, CHRIS;FERREIRA, CARA;LEYH, DAVID;SIGNING DATES FROM 20081103 TO 20081104;REEL/FRAME:055029/0612 Owner name: MDS NORDION, CANADA free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MDS NORDION;REEL/FRAME:055029/0768 Owner name: ALSERES PHARMACEUTICALS, INC., MASSACHUSETTS Effective Date: Mar 02, 2009 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THORN, RICHARD;REEL/FRAME:055029/0982 Owner name: ALSERES PHARMACEUTICALS, INC., MASSACHUSETTS Effective Date: Jun 03, 2009 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALSERES PHARMACEUTICALS, INC.;REEL/FRAME:055030/0102 Owner name: LIKEMINDS, INC., MASSACHUSETTS Effective Date: Jan 04, 2021 |
Nov 10, 2017 | PD | Priority Date | |
Sep 12, 2017 | I | Issuance | |
Aug 23, 2017 | STCF | INFORMATION ON STATUS: PATENT GRANT | free format text: PATENTED CASE |
Feb 05, 2015 | P | Published | |
Oct 17, 2014 | F | Filing |

Matter Detail

Renewals Detail
